David Glen Ripley, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 16 East St, Barre, VT 05641 Phone: 802-476-2020 Fax: 802-476-4818 |
Optical Expressions Berlin, Llc Optometrist Medicare: Medicare Enrolled Practice Location: 14 N Main St Ste 4002, Barre, VT 05641 Phone: 802-223-2090 Fax: 802-223-5336 |
Dr. James M. Foley, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 341 North Main Street, Barre, VT 05641 Phone: 802-476-7932 Fax: 802-479-5523 |
News Archive
Prion diseases are lethal neurodegenerative disorders that include Creutzfeldt-Jakob disease (CJD) in humans and bovine spongiform encephalopathy (BSE; commonly known as mad cow disease) in cows. A team of researchers, led by Adriano Aguzzi and Christina Sigurdson, at Universit-tsSpital Z-rich, Switzerland, has generated data in mice that provides greater understanding of the factors that determine how easy it is for prion diseases to be transmitted to a new host species.
Yoshimi Shibata, Ph.D., professor of biomedical science in the Charles E. Schmidt College of Medicine at Florida Atlantic University, has received a $380,552 grant from the National Institute of Complementary and Alternative Medicine of the National Institutes of Health to further investigate how microparticles called "chitin" found in crab, shrimp and lobster shells have anti-inflammatory mechanisms that could lead to the development of novel preventive and therapeutic strategies for individuals who suffer from inflammatory bowel disease (IBD) and others diseases.
Novation, the leading health care supply contracting company, announced today the addition of BIOTRONIK (Lake Oswego, OR) to its Cardiac Rhythm Management (CRM) Devices portfolio. This new 30-month agreement represents the first collaboration between the respective organizations.
As waves of hospitals move from older methods of record keeping to new digital electronic health record (EHR) systems, many medical professionals express fears that implementing an EHR system in their hospital will have dire results, including more errors and higher patient mortality.
Pharmaceutical and biotechnology major Wockhardt has received final approval from the United States Food & Drug Administration (US FDA) for marketing 5mg/ 5ml of Oxycodone HCl liquid which is used in treatment of moderate to severe acute and chronic pain. Wockhardt is launching the product soon and will be amongst the few generic versions of this product in the market.
› Verified 5 days ago